Literature DB >> 8570050

Vascular contrast enhancement in Lhermitte-Duclos disease: case report.

O Ortiz1, S Bloomfield, S Schochet.   

Abstract

We report a patient with surgically proven Lhermitte-Duclos disease. The radiologic and pathologic features of this cerebellar lesion are reviewed, including the newly reported presence of vascular contrast enhancement within the mass.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8570050     DOI： 10.1007/bf00593715

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  20 in total

1.  Immunohistochemistry and proliferative activity in Lhermitte-Duclos disease.

Authors:  L S Hair; F Symmans; J M Powers; P Carmel
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Recurrent Lhermitte-Duclos disease: report of two cases and association with Cowden's disease.

Authors:  D W Williams; A D Elster; L E Ginsberg; C Stanton
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jan-Feb       Impact factor: 3.825

3.  MR imaging of Lhermitte-Duclos disease: a case report.

Authors:  R R Smith; R I Grossman; H I Goldberg; D B Hackney; L T Bilaniuk; R A Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jan-Feb       Impact factor: 3.825

4.  Radiologic manifestations of Cowden disease.

Authors:  B M Gold; S Bagla; M H Zarrabi
Journal:  AJR Am J Roentgenol       Date:  1980-08       Impact factor: 3.959

5.  Lhermitte-Duclos disease: case report with computerized tomographic scan.

Authors:  W R Brown; J N Angelo; D L Kelly
Journal:  Neurosurgery       Date:  1980-02       Impact factor: 4.654

6.  Expression of neurofilament proteins in the hypertrophic granule cells of Lhermitte-Duclos disease: an explanation for the mass effect and the myelination of parallel fibers in the disease state.

Authors:  A T Yachnis; J Q Trojanowski; M Memmo; W W Schlaepfer
Journal:  J Neuropathol Exp Neurol       Date:  1988-05       Impact factor: 3.685

Review 7.  Clinical and radiological aspects of dysplastic gangliocytoma (Lhermitte-Duclos disease): a report of two cases with review of the literature.

Authors:  G Milbouw; J D Born; D Martin; J Collignon; P Hans; M Reznik; J Bonnal
Journal:  Neurosurgery       Date:  1988-01       Impact factor: 4.654

8.  Recurrent Lhermitte-Duclos disease in a child. Case report.

Authors:  S R Marano; P C Johnson; R F Spetzler
Journal:  J Neurosurg       Date:  1988-10       Impact factor: 5.115

9.  Lhermitte-Duclos disease and Cowden disease: a single phakomatosis.

Authors:  G W Padberg; J D Schot; G J Vielvoye; G T Bots; F C de Beer
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

10.  Multiple hamartoma syndrome (Cowden's disease).

Authors:  P E Weary; R J Gorlin; W C Gentry; J E Comer; K E Greer
Journal:  Arch Dermatol       Date:  1972-11
View more
  4 in total

Review 1.  Dysplastic gangliocytoma (Lhermitte-Duclos disease) associated with Cowden disease: report of a case and review of the literature for the genetic relationship between the two diseases.

Authors:  J Murata; M Tada; Y Sawamura; K Mitsumori; H Abe; K Nagashima
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Lhermitte-Duclos disease associated to Cowden syndrome: de novo diagnosis and management of these extremely rare syndromes in a patient.

Authors:  Ivo Gama; Leonor Almeida
Journal:  BMJ Case Rep       Date:  2017-01-30

3.  A case of Lhermitte-Duclos disease presenting high FDG uptake on FDG-PET/CT.

Authors:  Toshio Nakagawa; Masayuki Maeda; Mikiyoshi Kato; Naohiro Terada; Shigetoshi Shimizu; Yoshito Morooka; Hiroshi Nakano; Kan Takeda
Journal:  J Neurooncol       Date:  2007-02-27       Impact factor: 4.130

4.  Contrast enhancement in Lhermitte-Duclos disease of the cerebellum: correlation of imaging with neuropathology in two cases.

Authors:  L Spaargaren; P Cras; M A M Bomhof; S T Lie; A M de Barsy; P H Croese; J L J M Teepen; V H J M Duwel; J W Van Goethem; O Ozsarlak; L van den Hauwe; A M De Schepper; P M Parizel
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.